Identifying prodromal symptoms at high specificity for Parkinson’s disease

INTRODUCTION: To test drugs with the potential to prevent the onset of Parkinson’s disease (PD), it is key to identify individuals in the general population at high risk of developing PD. This is often difficult because most of the clinical markers are non-specific, common in PD but also common in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Holly, Anzures-Cabrera, Judith, Simuni, Tanya, Postuma, Ronald B., Marek, Kenneth, Pagano, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556459/
https://www.ncbi.nlm.nih.gov/pubmed/37810617
http://dx.doi.org/10.3389/fnagi.2023.1232387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556459/
https://www.ncbi.nlm.nih.gov/pubmed/37810617
http://dx.doi.org/10.3389/fnagi.2023.1232387

Ejemplares similares